News Psilocybin more efficient for rumination than common antidepressant: study The study assessed differences between psilocybin and escitalopram on common signs in MDD Natalia Buendia CalvilloSeptember 9, 2022
Psychedelics Xtalks to host upcoming webinar on psychedelic know-how Free virtual conference will discuss unique requisites of psychedelic clinical development Rowan DunneSeptember 7, 2022
Canada Field Trip facilitates beneficial psychedelic-assisted therapy for cancer patient Patient participated in ketamine and psilocybin sessions through the Special Access Program from Health Canada Rowan DunneSeptember 2, 2022
Canada Filament administers psilocybin to 14 participants in Health Canada sanctioned clinical trial Clinical trial will be conducted as part of the ATMA Journey Centre's psychedelic-assisted therapist training program Rowan DunneSeptember 1, 2022
Psychedelics Heroic Hearts collaborates with Maya to streamline psychedelic data for veterans Influencing policies, cataloguing proof of efficacy and assisting veterans integration processes will be ideal outcomes from partnership Rowan DunneSeptember 1, 2022
Canada Mindset Pharma discovers 3 novel next-gen psychedelic compounds Discovery of new drugs follows company decision to extend research outside of tryptamine class, i.e. psilocybin and DMT Rowan DunneAugust 31, 2022
Psychedelics Beond publishes ‘Ibogaine: A Clinical Summary’ Mexican clinical practice releases 'most complete and up-to-date known summary' regarding plant-derived psychoactive substance Rowan DunneAugust 31, 2022
Business Optimi enters psilocybin supply agreement to open healthcare centre in Costa Rica The psilocybin producer will be working with the Knowde Group, Inc., BC Green Pharmaceuticals Inc. and Promises Innovative Recovery (PIR) Natalia Buendia CalvilloAugust 30, 2022
Canada PharmAla Biotech applies for patent on 6 novel MDMA-like molecules Application follows successful pre-clinical animal studies at the University of Arkansas Rowan DunneAugust 29, 2022
Canada Clearmind’s psychoactive drug shows positive results for cocaine use disorder Novel proprietary psychedelic molecule continues to demonstrate potential for treating cocaine dependency Rowan DunneAugust 26, 2022